|
Video: What is a Stock Split?
|
|
Telik is a clinical-stage drug development company focused on discovering and developing small molecule drugs to treat cancer. TELINTRA, Co.'s lead drug candidate is a small molecule glutathione analog inhibitor of the enzyme glutathione S-transferase P1-1 (GST P1-1). Co. is developing TELINTRA for the treatment of blood disorders that are characterized by defects in blood formation with associated with low blood cell levels, such as anemia or thrombocytopenia. TELCYTA, Co.'s second product candidate, is a small molecule cancer drug designed to be activated in cancer cells. According to our TELK split history records, TELK has had 1 split. | |
|
TELK (TELK) has 1 split in our TELK split history database. The split for TELK took place on April 02, 2012. This was a 1 for 30 reverse split, meaning for each 30 shares of TELK owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 33.3333333333333 share position following the split.
When a company such as TELK conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the TELK split history from start to finish, an original position size of 1000 shares would have turned into 33.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into TELK shares, starting with a $10,000 purchase of TELK, presented on a split-history-adjusted basis factoring in the complete TELK split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/17/2014 |
|
End date: |
10/09/2014 |
|
Start price/share: |
$9.50 |
|
End price/share: |
$5.50 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-42.11% |
|
Annualized Gain: |
-698.56% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$5,789.00 |
|
Years: |
0.06 |
|
|
|
Date |
Ratio |
04/02/2012 | 1 for 30 |
|
|